Timothy Alexander

London Grove Township: Where Farmland, Fairways, and History Still Shape the Landscape The morning fog lingers over the fields just north of Chatham, softening fence lines and blurring the edges of distant barns. Along a narrow country […]

Apache Livy Gains Top-Level Status in Open-Source Milestone WILMINGTON, DE — The Apache Software Foundation has elevated Apache Livy to Top-Level Project status, a designation that signals the project’s g […]

Onfolio Launches AI Platforms to Expand Investor Relations Business WILMINGTON, DE — Onfolio Holdings Inc. (Nasdaq: ONFO, ONFOW) (OTC: ONFOP) has launched two artificial intelligence-driven software products targeting i […]

Global Indemnity Declares Distribution as Insurance Units Expand WILMINGTON, DE — Global Indemnity Group LLC (NASDAQ: GBLI) will distribute $0.35 per common share to shareholders later this month, returning capital t […]

Five Below Raises Outlook After Sales Surge Fuels Earnings PHILADELPHIA, PA — Five Below Inc. (NASDAQ: FIVE) raised its full-year sales and earnings outlook after reporting a sharp increase in first-quarter r […]

Vishay Targets EV Efficiency With New Power Module MALVERN, PA — Vishay Intertechnology Inc. (NYSE: VSH) has introduced a new power module aimed at reducing space requirements and improving power e […]

pharosIQ Launches Data Platform as AI Reshapes B2B Sales PHILADELPHIA, PA — pharosIQ has launched a new data-as-a-service offering aimed at helping businesses track buyer activity as artificial intelligence i […]

NextGen Pathology Adopts AI Platform to Expand Services PHILADELPHIA, PA — NextGen Pathology has selected Proscia’s Concentriq digital pathology platform as part of a strategy to expand subspecialty d […]

ICYMI: Medicus Advances SkinJect Into Registrational Study for Rare Disorder PHILADELPHIA, PA — Medicus Pharma Ltd. (NASDAQ: MDCX) has submitted a registrational study protocol to the U.S. Food and Drug Administration for its S […]

Madrigal Investors Focus on Rezdiffra Growth at Goldman Event CONSHOHOCKEN, PA — Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is set to present at the Goldman Sachs Global Healthcare Conference this week as i […]

Palvella Advances Rare Disease Drug Toward FDA Filing WAYNE, PA — Palvella Therapeutics Inc. (Nasdaq: PVLA) said it remains on track to submit a New Drug Application in the second half of 2026 for its l […]

Cabaletta Expands Autoimmune Strategy on Mid-Stage Data PHILADELPHIA, PA — Cabaletta Bio (Nasdaq: CABA) reported new clinical data suggesting its lead CAR-T cell therapy candidate could support regulatory f […]

Mineralys Restructures Drug Economics With $500 Million Financing RADNOR, PA — Mineralys Therapeutics (NASDAQ: MLYS) has agreed to eliminate future royalty obligations tied to its lead drug candidate lorundrostat w […]

Neuronetics Names Sales Chief, Grants Equity Incentive MALVERN, PA — Neuronetics Inc. (NASDAQ: STIM) has appointed healthcare sales executive Robert Greene as senior vice president of sales and awarded h […]

Orchestra BioMed Grants Equity Awards to New Employees NEW HOPE, PA — Orchestra BioMed Holdings Inc. (Nasdaq: OBIO) has granted stock options covering 85,500 shares to five newly hired employees, using an i […]

Callan Expands Advisory Services With Philanthropy Hire PHILADELPHIA, PA — Callan Family Office has hired philanthropic strategist George Burnette as director of philanthropic consulting and wealth, e […]

Obesity Survey Finds Gap Between Treatment Support and Use RADNOR, PA — New research comparing the views of primary care physicians and patients with obesity found broad acceptance of anti-obesity medications b […]

Angeion Names New CEO as Growth Strategy Enters Next Phase PHILADELPHIA, PA — Angeion Group has appointed veteran legal information executive Bill Carter as chief executive officer, a leadership change that s […]

Palvella Set for Goldman Conference Amid Rare Disease Push WAYNE, PA — Palvella Therapeutics (Nasdaq: PVLA) will present its development strategy to investors this week as the clinical-stage biotechnology c […]

SEED Advances Cancer Drug Into Human Trials, Targets Hard-to-Treat Tumors KING OF PRUSSIA, PA — SEED Therapeutics has advanced its lead cancer drug candidate, ST-01156, into a first-in-human clinical trial, a step that will t […]